Drug & medication recalls High risk

Glaxosmithkline Consumer Healthcare Holdings DBA Haleon recalls Advil Liqui Gels, Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsule…

Recall date
December 6, 2022
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
D-0182-2023
FDA classification
Class I
Brand / firm
Glaxosmithkline Consumer Healthcare Holdings DBA Haleon
Sold / distributed
Nationwide in the USA.

Why it was recalled

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.

What was recalled

Advil Liqui Gels, Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Distributed by: Pfizer, Madison, NJ 07940, UPC 3 0573 0169 49 3

Get recall alerts

Free email alert whenever Glaxosmithkline Consumer Healthcare Holdings DBA Haleon has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Glaxosmithkline Consumer Healthcare Holdings DBA Haleon